Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 23, 2018 08:00 ET | Source: Immune Pharmaceuticals, Inc.

Immune Pharmaceuticals Provides a Pipeline Update

ENGLEWOOD CLIFFS, N.J., May 23, 2018 (GLOBE NEWSWIRE) -- Immune Pharmaceuticals, Inc. (NASDAQ:IMNP) (“Immune” or the “Company”), a biopharmaceutical company developing novel therapeutic agents for...
May 15, 2018 09:00 ET | Source: Immune Pharmaceuticals, Inc.

Immune Pharmaceuticals Presents Updated Positive Results from Phase 2 Trial of Bertilimumab in Bullous Pemphigoid

- Results from all subjects confirm excellent safety and tolerability and a large benefit across a variety of efficacy measures despite aggressive prednisone tapering - - Positive data support...
May 07, 2018 08:30 ET | Source: Immune Pharmaceuticals, Inc.

Immune Pharmaceuticals Provides Update on Plans for Oncology Subsidiary, Cytovia, Inc.

ENGLEWOOD CLIFFS, New Jersey, May 07, 2018 (GLOBE NEWSWIRE) -- Immune Pharmaceuticals, Inc. (NASDAQ:IMNP) (“Immune” or the “Company”), a biopharmaceutical company developing novel therapeutic agents...